ThinkEquity LLC
17 State Street, 41st Floor
New York, NY 10004
February 9, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D.C. 20549
Attention: Jimmy McNamara
|
|
|
| RE: | MAIA Biotechnology, Inc. |
|
| Registration Statement on Form S-1 Filed February 6, 2023 File No. 333-269606 |
Ladies and Gentlemen:
As the underwriter of the proposed offering of MAIA Biotechnology, Inc. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated February 7, 2023 for the above-referenced Registration Statement.
| Very truly yours,
| |
|
THINKEQUITY LLC
| |
| By: | /s/ Eric Lord |
| Name: Eric Lord | |
| Title: Head of Investment Banking | |
